Canadian Institutes of Health Research
http://www.cihr-irsc.gc.ca
Common menu bar links
New Canada-HOPE scholarship program
The Canadian Institutes of Health Research (CIHR) via its collaborative CIHR/ Canada's Research-Based Pharmaceutical Companies (Rx&D) Research Program, in partnership with Aventis Pharma Inc., a member of the sanofi-aventis Group, have founded a scholarship program to further develop international collaborative efforts between researchers: Canada-HOPE Scholarship Program.
The goal of this Program is to enable promising scientists and clinicians from Low and Middle Income Countries, as identified by the Canadian International Development Agency and the United Nations, to be mentored by prominent Canadian researchers and to be exposed to some of the best science, laboratories and training environments in Canada.
The objective of this initiative is to develop research training opportunities with the potential to lead to the development of sustainable research programs to help people in developing countries. The pilot round of this Program will focus on sub-continental South Asia. It is the intent to gradually expand the Program to other regions of the world.
| Timelines: | |
| March 1, 2005 | Deadline for Full Application |
| May 1, 2005 | Phase I Review of the Full Application |
| Early June 2005 | Phase II Interview of Short-listed Applicants |
| Mid-late June 2005 | Notification of decision |
| Duration of the award | 4 years |
| Funds available | Up to 5 awards will be funded in the 1st round |
| Start date | As early as September 2005 |
The full request for application is available at:
www.cihr-irsc.gc.ca/e/25500.html
For further information on the Program, please contact:
Prabha Singh
CIHR
Tel.: 613-952-0823
E-mail: psingh@cihr-irsc.gc.ca
www.cihr-irsc.gc.ca/
Michel Tremblay
Aventis Pharma Inc., sanofi-aventis Group
Tel.: 514-956-4098
E-mail: michelg.tremblay@aventis.com
www.aventispharma.ca/
